May 7, 2024

Årsredovisning 2023

General
Regulatory

Välkommen att ladda ner Årsredovisning 2023.

More news from Micropos Medical

See all news

September 25, 2026

Hospital Meixoeiro do Vigo in Spain Treats Its First Patient with the Raypilot^® System

Hospital Meixoeiro do Vigo in Spain, has treated its first prostate cancer patient using Augmented Stereotactic Body Radiation Therapy (ASBRT) with support of the Raypilot System®. The treatment follows the installation of the system and training of the clinical team, expanding access to advanced radiotherapy techniques in the…

September 10, 2026

First Patient Treated with the Raypilot^® System at Medical University of South Carolina

The Medical University of South Carolina (MUSC) has successfully completed its first patient treatment using the Raypilot® System, marking the start of clinical use of the technology at the hospital. Following a successful installation, representatives from Micropos Medical were on-site in Charleston to support the clinical team during implementation and…

September 23, 2026

Swedes Treated for Prostate Cancer in Italy – A Method Associated with Fewer Side Effects

Over the past year, five Swedish men diagnosed with prostate cancer have chosen to undergo treatment at the University Hospital of Monza, Italy. There, they received a course of four radiation treatments delivered over a single week. The clinic uses modern radiotherapy with a high level of precision, a method…

July 1, 2026

Initial Clinical Treatments at Johns Hopkins Medicine Using Raypilot System

Micropos Medical AB today announced that the first five patients in the United States have been treated using the Raypilot® System as part of an early clinical evaluation at Johns Hopkins Medicine, one of the world’s leading academic healthcare institutions. The collaboration marks an important milestone for Micropos Medical and…

May 21, 2026

Årsredovisning 2025

Välkommen att ladda ner årsredovisningen för Micropos Medical 2025

May 4, 2026

Information om företrädesemission

Styrelsen i Micropos Medical AB (“Micropos” eller “Bolaget”) har tidigare fattat beslut om att med stöd av det bemyndigande som lämnades på årsstämman den 21 maj 2025 att genomföra en företrädesemission av aktier om 25 MSEK före avdrag för transaktionskostnader(“Företrädesemissionen”). Här kan du läsa all…

Follow Us on Social Media

Welcome to follow us for news, insights, and updates.